Zogenix (ZGNX) –
-
Form 15-12B ZOGENIX, INC.
-
Form SC 13G ZOGENIX, INC. Filed by: CARLSON CAPITAL L P
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Smith Michael P
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: BREITMEYER JAMES B
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Stutts Mary E.
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: WIGGINS MARK C
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: BOCK LOUIS C
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: TANNENBAUM RENEE P
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Farfel Gail M
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Galer Bradley S.
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: MAST ERLE T
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Loewy Caroline M
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: GARNER CAM L
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Mitchell Shawnte
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: FARR STEPHEN J
-
Form 4 ZOGENIX, INC. For: Mar 07 Filed by: Waynick Denelle J
-
Form EFFECT ZOGENIX, INC.
-
Form EFFECT ZOGENIX, INC.
-
UCB Completes Acquisition of Zogenix, Inc. (ZGNX)
-
UCB Completes Acquisition of Zogenix, Inc.
-
Form POS AM ZOGENIX, INC.
-
Form POS AM ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form S-8 POS ZOGENIX, INC.
-
Form 8-K ZOGENIX, INC. For: Mar 07
-
Form SC 14D9/A ZOGENIX, INC. Filed by: ZOGENIX, INC.
-
Form SC TO-T/A ZOGENIX, INC. Filed by: UCB S.A.
-
Form 25-NSE ZOGENIX, INC. Filed by: Nasdaq Stock Market LLC
-
Form 10-K/A ZOGENIX, INC. For: Dec 31
-
Form SC 14D9/A ZOGENIX, INC. Filed by: ZOGENIX, INC.
-
Form SC TO-T/A ZOGENIX, INC. Filed by: UCB S.A.
-
Zogenix (ZGNX) To Present New Long-term Data on FINTEPLA in Lennox-Gastaut Syndrome (LGS) at AAN
-
Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022
-
Form SC 14D9/A ZOGENIX, INC. Filed by: ZOGENIX, INC.
-
Form SC 14D9/A ZOGENIX, INC. Filed by: ZOGENIX, INC.
-
Form 10-K ZOGENIX, INC. For: Dec 31
-
Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations
-
Zogenix, Inc. (ZGNX) PT Raised to $27 at Northland Capital Markets
-
Northland Capital Markets Downgrades Zogenix, Inc. (ZGNX) to Market Perform
-
Needham & Company Reiterates Hold Rating on Zogenix (ZGNX) Following Earnings
-
Form 8-K ZOGENIX, INC. For: Feb 28
-
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
-
Form SC TO-T/A ZOGENIX, INC. Filed by: UCB S.A.
-
Form SC 14D9/A ZOGENIX, INC. Filed by: ZOGENIX, INC.
-
Form 8-K ZOGENIX, INC. For: Feb 17
Back to ZGNX Stock Lookup